Navigation Links
MoleSafe USA Expands Services to Leading Cancer Facilities at St. Joseph's/Candler and CentraState Medical Center
Date:5/26/2010

MILLBURN, N.J., May 26 /PRNewswire/ -- MoleSafe (www.molesafe.com), the world's most advanced melanoma screening program, announced today that it will offer its services at two of the nation's top medical centers by the end of 2010.  The following institutions will soon offer in-house MoleSafe clinics to provide their patients with cutting-edge skin cancer detection:

  • The Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler (Savannah, Georgia)
  • CentraState Medical Center (Freehold, New Jersey)

"We could not be more proud to align MoleSafe with these highly regarded medical centers that have each done so much to save and improve the lives of skin cancer patients.  The rapid growth and expansion of MoleSafe is a promising sign that Americans are continuing to become better educated on the very serious threat posed by melanoma, a disease that needlessly takes the lives of thousands of people each year," said Dr. Richard Bezozo, president of MoleSafe USA.

The adoption of MoleSafe by these leading cancer facilities follows the recent announcement that MoleSafe is offered at the renowned NYU Ronald O. Perelman Department of Dermatology in New York.  Launched in the U.S. in 2008, MoleSafe has expanded rapidly throughout the United States.  In addition to its medical center partnerships, MoleSafe operates stand-alone clinics in San Francisco, California; Charlotte, North Carolina; Albuquerque, New Mexico; and Millburn, New Jersey.

In addition to his role as president and founder of MoleSafe USA, Dr. Richard Bezozo is the lead blogger for "Melanoma Updates", a blog that details the latest developing information and technology on skin cancer prevention and detection. (www.melanomaupdates.com)

MoleSafe is part of an international network of forty melanoma screening centers located primarily in Australia and New Zealand, which have the highest rates of melanoma.  Using advanced technology developed by MoleMap New Zealand, Ltd, this network of clinics has conducted more than 135,000 examinations on 75,000 patients, imaged and diagnosed in excess of 1.5 million lesions, identifying close to 1,500 melanomas.

The MoleSafe four-pronged procedure represents a new standard of care and is part of a life-long program for the early detection of melanoma. It has four key elements:

  • Risk assessment: Using its database, MoleSafe has developed a risk assessment model that can help identify patients who may be at higher risk of melanoma;
  • Serial Digital Dermoscopy: Individual moles are imaged microscopically, and tagged to their location on the body for subsequent diagnosis, identification and comparison over time;
  • Diagnosis and Management: The patient's complete skin record, including digital images and clinical information, is sent via a secure tele-dermatology network to MoleSafe's panel of world-class melanoma dermatologists (dermoscopists) for analysis and reporting. Patients and their designated doctors receive their reports and their digital melanogram.
  • Education and Follow-up: The MoleSafe melanographer, a trained nurse, nurse practitioner or physician assistant educates patients about the risks of sun exposure, and helps generate a continuing partnership between MoleSafe, the patient and his/her doctor.  

To schedule an appointment for a MoleSafe screening at any one of these new locations, call 877-MOLESAFE (877- 665-3723).

About MoleSafe

MoleSafe (www.molesafe.com) is a state-of-the-art procedure involving the digital imaging, archiving and diagnosis of moles and other suspicious lesions. The procedure utilizes a combination of high resolution dermoscopy imaging technology that uses high intensity light to penetrate through the surface of the skin to show the structure of moles (and other lesions) and a dermatologist's expert evaluation of the images. In addition to the increased diagnostic accuracy associated with dermoscopy, MoleSafe is able to detect at an earlier stage any new, changing and/or suspicious lesions by monitoring and comparing the images over time. While MoleSafe has the ability to identify all skin cancers, its primary focus is on the early detection of melanoma.


'/>"/>
SOURCE MoleSafe
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Waters Expands Xevo MS Instrument Platform With Next-Generation Mass Spectrometers
2. West Haven Firm Expands Biomedical Disposal Program with Community Economic Development Fund
3. Connectyx Retains Services of CP Capital Securities as It Expands Its Presence in the $5 Billion US Electronic Health Record Market
4. SynCo Expands Agreement with OncoMed Pharmaceuticals to Manufacture Cancer Stem Cell Antibodies
5. Eye-Fi Expands Hotspot Access Service Worldwide
6. MyPunchbowl Expands Leadership Team With Veterans of Evite.com and Pizza Hut
7. Healthcare Web Site Expands Reach to Pharmacy Industry
8. Sigma-Aldrich Further Expands In Vivo Biology Offering by Signing an Agreement to Acquire Ace Animals, Inc.
9. URL Pharma Expands Colcrys(R) Patient Assistance Program
10. HIV Vaccine Strategy Expands Immune Responses
11. Volcano Expands Access to FFR with Ability to Integrate with the Majority of Hemodynamic Monitoring Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... Research and Markets has announced the addition of the "Global ... and Increasing Usage of Complex Biologics during the Forecast Period" ... The ... Billion in 2015 to around USD 26 Billion by 2020. ... Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during ...
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... 2017 , ... The doctors at Wall Centre Dental are now expanding their ... require sedation to receive dental care. The doctors offer three treatment options to put ... to oral surgery, at their dental office in Vancouver. Wall Centre Dental is currently ...
(Date:4/25/2017)... ... April 25, 2017 , ... As Spring reignites vigilance ... research related to Zika virus during pregnancy, as well as other prenatal exposures ... science. , The Teratology Society is an international and multidisciplinary ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, ... to its patient care management module. Using this new feature, sleep physicians can ... been initiated on continuous positive airway pressure (CPAP), oral, or other forms of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, developer, ... strategic partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a charitable ... management of complex spine deformity cases, particularly in children. , GSO’s focus is ...
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project was honored ... 2.0 — the American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. ... telemedicine to improve the lives of the poor and underserved in other parts of ...
Breaking Medicine News(10 mins):